Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO 2019 1000x250

The ESMO Congress 2019 was the global stage for the exchange and debate of translational cancer science of excellence, first announcements of potentially practice changing data, and multidisciplinary must-have conversations set to spur transformative therapies against cancer.

In 2019 we are proud to announce another record – 3,904 submitted abstracts, representing a 16% increase from ESMO Congress 2018.

View programme online


ESMO-MORA: The Congress programme has been accredited with ESMO-MORA category 1 points accreditation. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details


The Congress webcasts include all the sessions of the official programme, where speaker permission is granted, and are available on the page dedicated to meeting resources on this is website and OncologyPRO for ESMO members.

Access all the resources from ESMO Congress 2019

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings